Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 73
Filter
1.
Tech Coloproctol ; 24(9): 971-975, 2020 09.
Article in English | MEDLINE | ID: mdl-32601752

ABSTRACT

BACKGROUND: The exact pathophysiology of diverticulitis is not well understood and may be multifactorial. Recent studies highlight dysbiosis as a plausible mechanism. FMT is a safe strategy to restore commensal colon microbiota and has proven to be an effective treatment for gastrointestinal dysbiosis such as Clostridium difficile infection (CDI). There have been no studies reporting the treatment of diverticulitis with FMT. Our aim was to describe the novel application of fecal microbiota transplantation (FMT) for the treatment of recurrent diverticulitis. CASE: We report a case of a 63-year-old woman who had a 13-year history of multiply recurrent and multifocal diverticulitis previously treated with numerous short courses of intravenous and oral antibiotics for acute flares, two segmental colon resections, and suppressive antibiotic therapy for recurrent disease. Secondary to multiple courses of antibiotics , the patient developed CDI. She was treated with a single round of FMT and subsequently stopped all antibiotics at the time of FMT. RESULTS: In 20 months of follow-up, the patient has had no further recurrence of diverticulitis or CDI. CONCLUSIONS: FMT could prove to be a novel therapy for refractory diverticulitis but requires further investigation.


Subject(s)
Clostridioides difficile , Clostridium Infections , Diverticulitis , Fecal Microbiota Transplantation , Feces , Female , Humans , Middle Aged , Recurrence , Treatment Outcome
2.
Eye (Lond) ; 18(1): 27-34, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14707961

ABSTRACT

The principal pathways serving higher visual function comprise the dorsal stream and the ventral stream. The dorsal stream runs between the occipital lobes and the parietal lobes and subserves the ability to process the whole visual scene and carry out visually guided movement. The ventral stream runs between the occipital lobes and temporal lobe tissue and primarily subserves visual recognition and memory. These tissues are susceptible to dysfunction in children with brain damage. We report a series of 40 children in whom damage to the brain has led to a common symptom complex affecting vision. Lower visual field loss was frequently elicited. This was associated with impaired ability to make accurate visually guided movement (particularly of the lower limbs) accompanied by impaired simultaneous perception, and in some cases, with inaccurate saccades and in others, impaired perception of movement. These features are consistent with parietal/dorsal stream dysfunction. Difficulty recognising faces and problems with route finding (which are ventral stream functions) were also present in a number of the children. These visual difficulties can be manifest in the presence of normal visual acuity. Recognition of these problems leads to understanding of the child's visual difficulties and facilitates adaptation of curriculum delivery at school.


Subject(s)
Brain Damage, Chronic/complications , Perceptual Disorders/etiology , Vision Disorders/etiology , Adolescent , Agnosia/etiology , Brain Damage, Chronic/psychology , Child , Child, Preschool , Humans , Male , Motion Perception , Psychomotor Performance , Retrospective Studies , Saccades , Vision, Binocular , Visual Acuity , Visual Fields , Visual Pathways
3.
Internet resource in English | LIS -Health Information Locator | ID: lis-5580

ABSTRACT

It presents recommendations are made regarding the diagnosis of anthrax, indications for vaccination, therapy for those exposed, postexposure prophylaxis, decontamination of the environment, and additional research needs. Published in JAMA, 281:1735-1745, 1999. Document in pdf format; Acrobat Reader required.


Subject(s)
Anthrax/diagnosis , Anthrax/therapy , Anthrax/epidemiology , Bioterrorism
4.
JAMA ; 285(21): 2763-73, 2001 Jun 06.
Article in English | MEDLINE | ID: mdl-11386933

ABSTRACT

OBJECTIVE: The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals if tularemia is used as a biological weapon against a civilian population. PARTICIPANTS: The working group included 25 representatives from academic medical centers, civilian and military governmental agencies, and other public health and emergency management institutions and agencies. EVIDENCE: MEDLINE databases were searched from January 1966 to October 2000, using the Medical Subject Headings Francisella tularensis, Pasteurella tularensis, biological weapon, biological terrorism, bioterrorism, biological warfare, and biowarfare. Review of these references led to identification of relevant materials published prior to 1966. In addition, participants identified other references and sources. CONSENSUS PROCESS: Three formal drafts of the statement that synthesized information obtained in the formal evidence-gathering process were reviewed by members of the working group. Consensus was achieved on the final draft. CONCLUSIONS: A weapon using airborne tularemia would likely result 3 to 5 days later in an outbreak of acute, undifferentiated febrile illness with incipient pneumonia, pleuritis, and hilar lymphadenopathy. Specific epidemiological, clinical, and microbiological findings should lead to early suspicion of intentional tularemia in an alert health system; laboratory confirmation of agent could be delayed. Without treatment, the clinical course could progress to respiratory failure, shock, and death. Prompt treatment with streptomycin, gentamicin, doxycycline, or ciprofloxacin is recommended. Prophylactic use of doxycycline or ciprofloxacin may be useful in the early postexposure period.


Subject(s)
Biological Warfare , Civil Defense/standards , Disease Outbreaks/prevention & control , Tularemia/prevention & control , Anti-Bacterial Agents/therapeutic use , Bacterial Vaccines , Bioterrorism , Decontamination , Francisella tularensis/pathogenicity , Humans , Infection Control , Tularemia/diagnosis , Tularemia/epidemiology , Tularemia/etiology , United States/epidemiology , Vaccination , Vaccines, Attenuated , Virulence
5.
Palliat Med ; 14(3): 205-7, 2000 May.
Article in English | MEDLINE | ID: mdl-10858828

ABSTRACT

Varying concentrations of octreotide acetate (Sandostatin) and diamorphine hydrochloride were prepared and stored in polypropylene syringes at 37 degrees C in the dark. The solutions were analysed for octreotide acetate content using a validated HPLC method at regular intervals over a 48-h period. The results indicate that octreotide acetate remains stable in the presence of diamorphine hydrochloride at 37 degrees C for 24 h. In addition, the solutions prepared maintained their clarity, with no signs of precipitation upon visual examination under normal light conditions.


Subject(s)
Analgesics, Opioid/chemistry , Gastrointestinal Agents/chemistry , Heroin/chemistry , Octreotide/chemistry , Drug Combinations , Drug Stability , Drug Storage , Humans , Palliative Care , Syringes
6.
JAMA ; 283(17): 2281-90, 2000 May 03.
Article in English | MEDLINE | ID: mdl-10807389

ABSTRACT

OBJECTIVE: The Working Group on Civilian Biodefense has developed consensus-based recommendations for measures to be taken by medical and public health professionals following the use of plague as a biological weapon against a civilian population. PARTICIPANTS: The working group included 25 representatives from major academic medical centers and research, government, military, public health, and emergency management institutions and agencies. EVIDENCE: MEDLINE databases were searched from January 1966 to June 1998 for the Medical Subject Headings plague, Yersinia pestis, biological weapon, biological terrorism, biological warfare, and biowarfare. Review of the bibliographies of the references identified by this search led to subsequent identification of relevant references published prior to 1966. In addition, participants identified other unpublished references and sources. Additional MEDLINE searches were conducted through January 2000. CONSENSUS PROCESS: The first draft of the consensus statement was a synthesis of information obtained in the formal evidence-gathering process. The working group was convened to review drafts of the document in October 1998 and May 1999. The final statement incorporates all relevant evidence obtained by the literature search in conjunction with final consensus recommendations supported by all working group members. CONCLUSIONS: An aerosolized plague weapon could cause fever, cough, chest pain, and hemoptysis with signs consistent with severe pneumonia 1 to 6 days after exposure. Rapid evolution of disease would occur in the 2 to 4 days after symptom onset and would lead to septic shock with high mortality without early treatment. Early treatment and prophylaxis with streptomycin or gentamicin or the tetracycline or fluoroquinolone classes of antimicrobials would be advised.


Subject(s)
Biological Warfare/prevention & control , Plague/prevention & control , Yersinia pestis , Anti-Bacterial Agents/therapeutic use , Civil Defense , Decontamination , Disaster Planning , Humans , Infection Control , Plague/epidemiology , Plague/physiopathology , Plague Vaccine , Violence , Virulence , Yersinia pestis/pathogenicity
9.
JAMA ; 281(22): 2127-37, 1999 Jun 09.
Article in English | MEDLINE | ID: mdl-10367824

ABSTRACT

OBJECTIVE: To develop consensus-based recommendations for measures to be taken by medical and public health professionals following the use of smallpox as a biological weapon against a civilian population. PARTICIPANTS: The working group included 21 representatives from staff of major medical centers and research, government, military, public health, and emergency management institutions and agencies. Evidence The first author (D.A.H.) conducted a literature search in conjunction with the preparation of another publication on smallpox as well as this article. The literature identified was reviewed and opinions were sought from experts in the diagnosis and management of smallpox, including members of the working group. CONSENSUS PROCESS: The first draft of the consensus statement was a synthesis of information obtained in the evidence-gathering process. Members of the working group provided formal written comments that were incorporated into the second draft of the statement. The working group reviewed the second draft on October 30, 1998. No significant disagreements existed and comments were incorporated into a third draft. The fourth and final statement incorporates all relevant evidence obtained by the literature search in conjunction with final consensus recommendations supported by all working group members. CONCLUSIONS: Specific recommendations are made regarding smallpox vaccination, therapy, postexposure isolation and infection control, hospital epidemiology and infection control, home care, decontamination of the environment, and additional research needs. In the event of an actual release of smallpox and subsequent epidemic, early detection, isolation of infected individuals, surveillance of contacts, and a focused selective vaccination program will be the essential items of an effective control program.


Subject(s)
Biological Warfare , Communicable Disease Control/standards , Disease Outbreaks/prevention & control , Smallpox/prevention & control , Biological Warfare/history , Biological Warfare/prevention & control , Decontamination , History, 18th Century , History, 19th Century , History, 20th Century , Humans , Immunization, Passive/adverse effects , Immunoglobulins/administration & dosage , Immunoglobulins/adverse effects , Infection Control , Research , Smallpox/epidemiology , Smallpox/history , Smallpox/physiopathology , Smallpox Vaccine/administration & dosage , Smallpox Vaccine/adverse effects , Smallpox Vaccine/history , Vaccination/adverse effects , Variola virus/pathogenicity
10.
JAMA ; 281(18): 1735-45, 1999 May 12.
Article in English | MEDLINE | ID: mdl-10328075

ABSTRACT

OBJECTIVE: To develop consensus-based recommendations for measures to be taken by medical and public health professionals following the use of anthrax as a biological weapon against a civilian population. PARTICIPANTS: The working group included 21 representatives from staff of major academic medical centers and research, government, military, public health, and emergency management institutions and agencies. EVIDENCE: MEDLINE databases were searched from January 1966 to April 1998, using the Medical Subject Headings anthrax, Bacillus anthracis, biological weapon, biological terrorism, biological warfare, and biowarfare. Review of references identified by this search led to identification of relevant references published prior to 1966. In addition, participants identified other unpublished references and sources. CONSENSUS PROCESS: The first draft of the consensus statement was a synthesis of information obtained in the formal evidence-gathering process. Members of the working group provided formal written comments which were incorporated into the second draft of the statement. The working group reviewed the second draft on June 12, 1998. No significant disagreements existed and comments were incorporated into a third draft. The fourth and final statement incorporates all relevant evidence obtained by the literature search in conjunction with final consensus recommendations supported by all working group members. CONCLUSIONS: Specific consensus recommendations are made regarding the diagnosis of anthrax, indications for vaccination, therapy for those exposed, postexposure prophylaxis, decontamination of the environment, and additional research needs.


Subject(s)
Anthrax , Biological Warfare , Public Health , Adolescent , Adult , Anthrax/diagnosis , Anthrax/drug therapy , Anthrax/prevention & control , Bacillus anthracis/immunology , Bacterial Vaccines , Child , Child, Preschool , Decontamination , Environmental Exposure , Female , Humans , Immunocompromised Host , Infant , Infection Control , Male , Pregnancy , United States , Vaccination , Vaccines, Inactivated
11.
J Pharm Biomed Anal ; 21(2): 327-30, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10703987

ABSTRACT

The determination of octreotide acetate in compound formulations of Sandostatin and diamorphine hydrochloride by RP-LC is described. Octreotide acetate, diamorphine hydrochloride and their respective degradants, [des-Thr-ol8]-octreotide and 6-O-acetylmorphine, were baseline resolved using a Lichrospher-60 RP-select B column with a mobile phase composition of acetonitrile/phosphate buffer (pH 7.4, 20 mM) (35:65 v/v) with UV detection at 210 nm. The method is simple, selective, precise and suitable for the determination of octreotide acetate in admixture.


Subject(s)
Heroin/analysis , Octreotide/analysis , Buffers , Chemistry, Pharmaceutical , Chromatography, High Pressure Liquid/methods , Drug Combinations , Heroin/chemistry , Hydrogen-Ion Concentration , Molecular Structure , Octreotide/chemistry
12.
Emerg Infect Dis ; 4(3): 493-4, 1998.
Article in English | MEDLINE | ID: mdl-9716982
16.
Clin Infect Dis ; 14(5): 1149-58, 1992 May.
Article in English | MEDLINE | ID: mdl-1600020

ABSTRACT

Epidemic, louse-borne typhus persists in the rugged, mountainous areas of Ethiopia and much of northeastern and central Africa as well as in the rural highlands of Central and South America, where the conditions of living favor the harboring of body lice and where antibiotic treatment and effective louse-control measures are unavailable. The historical significance and current epidemiology of typhus, including the reservoir of Rickettsia prowazekii in flying squirrels in the United States, are reviewed, and the clinical presentation, laboratory findings, and hospital course in the cases of 60 patients admitted with epidemic, louse-borne typhus to the St. Paul's Hospital in Addis Ababa, Ethiopia, are described. Treatment of this disease with oral doxycycline, tetracycline, or chloramphenicol prevents complications and results in prompt resolution of symptoms.


Subject(s)
Disease Outbreaks , Disease Reservoirs , Rickettsia prowazekii/isolation & purification , Sciuridae , Typhus, Epidemic Louse-Borne/epidemiology , Adolescent , Adult , Africa/epidemiology , Animals , Blood Cells , Blood Chemical Analysis , Ethiopia/epidemiology , Female , Humans , Male , Middle Aged , Typhus, Epidemic Louse-Borne/blood , Typhus, Epidemic Louse-Borne/urine , Urine/chemistry , Urine/cytology
17.
Eur J Epidemiol ; 7(3): 270-5, 1991 May.
Article in English | MEDLINE | ID: mdl-1884778

ABSTRACT

Rickettsioses have nonspecific clinical manifestations, making them difficult to diagnose in a clinical setting. Laboratory testing is usually needed to confirm the diagnosis. Rickettsial isolation is a sensitive and specific diagnostic technique, but the hazards associated with handling pathogenic rickettsiae usually preclude isolation attempts in most laboratories. Rickettsiae can also be detected in infected tissues by fluorescein-labeled antisera or by immunoperoxidase staining, but these techniques lack sensitivity, except when applied to postmortem tissue specimens. However, rickettsial DNA can be detected in acute phase blood specimens by polymerase chain reaction (PCR) technology, and this technique offers the prospect of prompt diagnosis and treatment. Serologic testing remains the most frequently used approach to diagnosis, although antibody tests usually fail to identify rickettsioses early enough to affect the management of individual patients. Available serologic techniques vary considerably in their sensitivity and specificity. Enzyme-linked immunosorbent assays (ELISA) are extremely sensitive, but the general unavailability of specific diagnostic antigens reduces the specificity of this and other serologic techniques. Molecular characterization of rickettsial antigens may soon allow the production of peptide antigens that are specific for each species and could maximize the specificity of test results. No diagnostic technique has any value unless it is applied successfully to the appropriate patient population. Improved surveillance of rickettsial diseases is urgently needed to identify specific areas in which rickettsioses are endemic. Such surveillance data would promote awareness of rickettsioses among local physicians and increase the probability that individual patients with rickettsioses would be identified promptly and receive appropriate therapy early in the course of their illness.


Subject(s)
Rickettsia Infections/diagnosis , DNA, Bacterial/analysis , Humans , Polymerase Chain Reaction , Sensitivity and Specificity , Serologic Tests
18.
Med J Aust ; 154(2): 99-104, 1991 Jan 21.
Article in English | MEDLINE | ID: mdl-1898756

ABSTRACT

Twenty-six cases of a spotted-fever-like illness have been identified on Flinders Island, Tasmania, over a 17 year period. These patients and 335 healthy persons from the island were investigated serologically using the Weil-Felix agglutination test (Proteus sp. antigens OX2, OX19, OXK) and rickettsia-specific microimmunofluorescence. The antigens used in these latter tests comprised one member of the typhus group (Rickettsia typhi) and three members of the spotted fever group (Rickettsia rickettsii, Rickettsia australis and Rickettsia conorii). Patients with Flinders Island spotted fever showed a higher prevalence of positive reactions to the Weil-Felix tests (with OX2 and OX19 antigens) and a higher prevalence of positive results to rickettsia-specific serological tests (with the exception of antibodies to Rickettsia typhi) than did healthy persons; OX2 (36% v. less than 1%); OX19 (36% v. less than 1%); Rickettsia rickettsii (42% v. 1%); Rickettsia australis (46% v. 1%); Rickettsia conorii (42% v. 1%); Rickettsia typhi (4% v. 4%). In seven of the 26 patients (27%) seroconversion was demonstrated by means of Weil-Felix tests, confirming recent infection. In six of these patients seroconversion was also demonstrated in rickettsia-specific tests. Although these results support the clinical evidence that the illness on Flinders Island is caused by a rickettsia of the spotted fever group, the aetiological agent remains to be isolated.


Subject(s)
Antibodies, Bacterial/analysis , Rickettsia Infections/immunology , Acute Disease , Adolescent , Adult , Aged , Agglutination Tests/methods , Child, Preschool , Female , Fluorescent Antibody Technique , Humans , Infant , Male , Middle Aged , Prevalence , Rickettsia rickettsii/immunology , Rickettsia typhi/immunology , Tasmania/epidemiology
19.
J Infect Dis ; 161(4): 609-17, 1990 Apr.
Article in English | MEDLINE | ID: mdl-2181027

ABSTRACT

Ehrlichiae are one of several kinds of obligate intracellular bacteria. Taxonomically, they are grouped with rickettsiae, but they can be distinguished by their unique tropism for circulating leukocytes. Ehrlichia canis causes a pancytopenia in dogs that becomes chronic if untreated. Certain breeds develop severe infections, characterized by fever, anorexia, dramatic weight loss, marked pancytopenia, anemia, peripheral edema, and hemorrhage. Ehrlichia risticii, a recently discovered species, is the cause of a serious diarrheal disease of horses. Other species of ehrlichiae have been documented as being veterinary pathogens. Recent data indicate that E. canis or a closely related species causes an acute febrile illness in humans. Clinically, the disease is similar to Rocky Mountain spotted fever, except that most patients do not have a rash. Human ehrlichiosis appears to be tickborne and is prevalent primarily in the southern Atlantic and south-central states. A mild from of ehrlichiosis has also been documented.


Subject(s)
Dog Diseases , Horse Diseases/microbiology , Rickettsiaceae Infections , Animals , Dog Diseases/epidemiology , Dog Diseases/microbiology , Dogs , Ehrlichia/ultrastructure , Horse Diseases/epidemiology , Horses , Humans , Leukocytes/microbiology , Rickettsiaceae Infections/epidemiology , Rickettsiaceae Infections/microbiology , Rickettsiaceae Infections/veterinary , United States/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...